ADULT T ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for ADULT T ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ADULT T ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ADULT T ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cancer drug boost chemo for tough blood cancers?
Disease control OngoingThis study tests whether adding the drug bortezomib to standard chemotherapy helps children and young adults with newly diagnosed T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma. About 847 participants received either chemo alone or chemo plus bortezomib. The…
Matched conditions: ADULT T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:26 UTC
-
New combo therapy shows promise in controlling tough leukemia
Disease control OngoingThis study looks at a powerful mix of chemotherapy drugs (Hyper-CVAD and dasatinib) for people with a specific genetic type of acute lymphoblastic leukemia (Ph+ ALL). Some participants also receive a donor stem cell transplant. The goal is to see how well this approach controls t…
Matched conditions: ADULT T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:49 UTC